CWM
REGN icon

CIBC World Markets’s Regeneron Pharmaceuticals REGN Stock Holding History

CIBC World Markets’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$14.8M Buy
+19,155
New +$13M 0.07% 183
2025
Q2 		$10.9M Buy
20,752
+7,932
+62% +$4.43M 0.07% 227
2025
Q1 		$8.13M Sell
12,820
-6,333
-33% -$4.36M 0.06% 209
2024
Q4 		$13.6M Buy
19,153
+2,201
+13% +$1.85M 0.08% 182
2024
Q3 		$17.8M Sell
16,952
-4,664
-22% -$5.19M 0.13% 129
2024
Q2 		$22.7M Buy
21,616
+3,834
+22% +$3.72M 0.15% 103
2024
Q1 		$17.1M Sell
17,782
-21,714
-55% -$20.6M 0.11% 131
2023
Q4 		$34.7M Buy
39,496
+21,325
+117% +$17.6M 0.19% 89
2023
Q3 		$15M Sell
18,171
-3,497
-16% -$2.75M 0.15% 111
2023
Q2 		$15.6M Buy
21,668
+14,942
+222% +$11.5M 0.13% 129
2023
Q1 		$5.53M Sell
6,726
-52,136
-89% -$39.3M 0.09% 178
2022
Q4 		$42.5M Buy
58,862
+57,236
+3,520% +$42.2M 0.29% 62
2022
Q3 		$1.12M Sell
1,626
-11,941
-88% -$7.52M 0.02% 346
2022
Q2 		$8.02M Sell
13,567
-11,478
-46% -$7.46M 0.08% 158
2022
Q1 		$17.5M Buy
25,045
+2,794
+13% +$1.77M 0.14% 116
2021
Q4 		$14.1M Sell
22,251
-5,608
-20% -$3.45M 0.07% 154
2021
Q3 		$16.9M Buy
27,859
+19,456
+232% +$12.1M 0.11% 127
2021
Q2 		$4.69M Sell
8,403
-5,662
-40% -$2.87M 0.03% 271
2021
Q1 		$6.66M Sell
14,065
-14,630
-51% -$7.12M 0.04% 245
2020
Q4 		$13.9M Buy
28,695
+1,824
+7% +$985K 0.07% 191
2020
Q3 		$15M Buy
26,871
+10,437
+64% +$6.33M 0.15% 152
2020
Q2 		$10.2M Buy
16,434
+1,667
+11% +$946K 0.11% 166
2020
Q1 		$7.21M Sell
14,767
-28,986
-66% -$12M 0.09% 178
2019
Q4 		$16.4M Buy
43,753
+11,167
+34% +$3.76M 0.11% 193
2019
Q3 		$9.04M Sell
32,586
-60,384
-65% -$17.9M 0.08% 234
2019
Q2 		$29.1M Buy
92,970
+44,208
+91% +$14.7M 0.22% 114
2019
Q1 		$20M Buy
48,762
+22,820
+88% +$9.4M 0.16% 134
2018
Q4 		$9.69M Buy
25,942
+1,953
+8% +$715K 0.09% 206
2018
Q3 		$9.69M Buy
23,989
+6,800
+40% +$2.59M 0.08% 222
2018
Q2 		$5.93M Buy
17,189
+2,872
+20% +$898K 0.05% 322
2018
Q1 		$4.93M Sell
14,317
-12,863
-47% -$4.47M 0.05% 294
2017
Q4 		$10.2M Sell
27,180
-37,678
-58% -$15.3M 0.07% 211
2017
Q3 		$29M Buy
64,858
+46,326
+250% +$22M 0.28% 80
2017
Q2 		$9.1M Sell
18,532
-29,015
-61% -$12.7M 0.1% 206
2017
Q1 		$18.4M Buy
47,547
+42,340
+813% +$15.7M 0.15% 119
2016
Q4 		$1.91M Buy
5,207
+3,125
+150% +$1.19M 0.02% 303
2016
Q3 		$837K Sell
2,082
-4,832
-70% -$1.94M 0.02% 200
2016
Q2 		$2.42M Buy
6,914
+645
+10% +$248K 0.06% 121
2016
Q1 		$2.26M Sell
6,269
-2,302
-27% -$949K 0.05% 130
2015
Q4 		$4.65M Buy
8,571
+1,531
+22% +$830K 0.09% 128
2015
Q3 		$3.27M Buy
7,040
+4,129
+142% +$2.22M 0.09% 132
2015
Q2 		$1.49M Buy
+2,911
New +$1.42M 0.05% 117

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CIBC World Markets's REGN Position: Q4 2025 in Review

CIBC World Markets opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2025: 19,155 shares worth $14.8M. The stake represents 0.07% of the portfolio and ranks #183 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in REGN as recently as Q2 2025.

CIBC World Markets first reported a position in REGN in Q2 2015 and has held it in 42 quarters since. The position peaked at $42.5M in Q4 2022. 1,385 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • CIBC World Markets held 19,155 shares of Regeneron Pharmaceuticals worth $14.8M as of Q4 2025.
  • Regeneron Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • Regeneron Pharmaceuticals made up 0.07% of CIBC World Markets's portfolio in Q4 2025, its #183 holding.
  • CIBC World Markets first reported a position in Regeneron Pharmaceuticals in Q2 2015 and has held it in 42 quarters since.
  • CIBC World Markets's Regeneron Pharmaceuticals position peaked at $42.5M in Q4 2022.
  • 1,385 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.